Unknown Manufacturer
Triptorelin is a GnRH agonist indicated for the palliative treatment of advanced prostate cancer.
Triptorelin is a GnRH agonist indicated for the palliative treatment of advanced prostate cancer.
Triptorelin is a synthetic agonist analog of gonadotropin releasing hormone (GnRH). Animal studies comparing triptorelin to native GnRH found that triptorelin had 13 fold higher releasing activity for luteinizing hormone, and 21-fold higher releasing activity for follicle-stimulating hormone.
Triptorelin is indicated for the palliative treatment of advanced prostate cancer.
1 associated conditions
